2
Total investments
1
Early stage
0
Mid stage
1
Late stage
8y
Years active
Portfolio
2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Apr 2020
Embr Labs is a Boston-based technology startup with patented wearable technology that goes beyond sensing. Our wearable thermal technology provides heating and cooling at the touch of a button and is already helping tens of thousands of people live better lives through personal temperature control. We are a science-driven team of interdisciplinary, collaborative, and compassionate people on a mission to harness the body’s natural response to temperature to enhance human wellbeing. Our technology was invented by the company’s founders while at MIT; we are backed by DigiTx Partners, Safar Partners, Bose Ventures and Intel Capital, and we have partnered with companies like Johnson & Johnson.
Board Member
Jan 2018
As the leading global authority on the evolution of digital health technology, Digital Therapeutics Alliance (DTA) is a 501(c)(6) non-profit trade association of industry leaders and stakeholders dedicated to the understanding, adoption, and integration of digital therapeutics into healthcare. DTA works to enable expanded access to high quality, evidence-based digital therapeutics for patients, clinicians, and payors to improve clinical and health economic outcomes. As the leading international organization on digital therapeutic thought leadership and education, DTA provides the digital health ecosystem with the necessary tools to define, evaluate, and utilize DTx products. For more information, please visit: www.dtxalliance.org.
Experience · 4 entries
All (4)
Investments (2)
Board (2)
2022
Entrepreneur in Residence
Sep 2022
Yale innovation has the potential to change the world. Launched by Yale University in 2022, Yale Ventures seeks to foster and accelerate a vibrant entrepreneurship and innovation ecosystem that increases support, resources, and opportunities for Yale innovators—faculty and students—as they translate their ideas and discoveries into new ventures that will positively impact the worlds greatest challenges.
2020
Board Member
Apr 2020
Embr Labs is a Boston-based technology startup with patented wearable technology that goes beyond sensing. Our wearable thermal technology provides heating and cooling at the touch of a button and is already helping tens of thousands of people live better lives through personal temperature control. We are a science-driven team of interdisciplinary, collaborative, and compassionate people on a mission to harness the body’s natural response to temperature to enhance human wellbeing. Our technology was invented by the company’s founders while at MIT; we are backed by DigiTx Partners, Safar Partners, Bose Ventures and Intel Capital, and we have partnered with companies like Johnson & Johnson.
2018
Board Member
Jan 2018
As the leading global authority on the evolution of digital health technology, Digital Therapeutics Alliance (DTA) is a 501(c)(6) non-profit trade association of industry leaders and stakeholders dedicated to the understanding, adoption, and integration of digital therapeutics into healthcare. DTA works to enable expanded access to high quality, evidence-based digital therapeutics for patients, clinicians, and payors to improve clinical and health economic outcomes. As the leading international organization on digital therapeutic thought leadership and education, DTA provides the digital health ecosystem with the necessary tools to define, evaluate, and utilize DTx products. For more information, please visit: www.dtxalliance.org.
2008
Director, Lifecycle Management and Portfolio Optimization
2008
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities.
We apply deep understanding of human biology and leverage different modalities, to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.
With approximately 7,000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Baar, Switzerland and we have world-class manufacturing facilities in North Carolina and Solothurn, Switzerland. We offer therapies globally through direct affiliate presence in 30 countries and a network of distribution partners in over 50 additional countries.
For more information, please visit www.biogen.com. Community Guidelines: https://www.biogen.com/community-guidelines.html
Follow us on social media – LinkedIn, Facebook, X, and YouTube.
